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Background: Cervical cancer is a deadly disease with high incidence rates in the world and in In-
donesia. In Kediri, East Java, there were 33 women who had cervical cancer in 2016, 3 of them 
died. Cervical cancer is caused by type 16 and type 18 Human Papilloma Viruses (HPV).  This dise-
ase can be prevented by the application of HPV vaccine. This study aimed to examine factors asso-
ciated with the use of HPV vaccine for the prevention of cervical cancer among women in Kediri, 
East Java, using health belief model (HBM). 
Subjects and Method: This was an analytic observational study with case control design. This 
study was conducted in Kediri, East Java, from February 10 to March 10, 2017. A sample of 120 
women consisting of 40 women who had used HPV vaccine and 80 women who had not used HPV 
vaccine, were selected for this study by fixed disease sampling. The dependent variable was use of 
HPV vaccine. The independent variables were perceived susceptibility, perceived severity, percei-
ved benefit, perceived threat, perceived barrier, and cues to action. The data were collected by a set 
of pre-tested questionnaire. Logistic regression was employed for data analysis.  
Results: The use of HPV vaccine was associated with perceived susceptibility (OR= 0.79; 95% CI= 
0.23 to 2.70; p= 0.710), perceived severity (OR= 5.19; 95% CI= 1.30 to 20.66; p= 0.019),  perceived 
threat (OR= 1.04; 95% CI= 0.32 to 3.35; p= 0.942), perceived benefit (OR= 1.33; 95% CI= 0.40 to 
4.38; p= 0.638),  perceived barrier (OR= 0.42; 95% CI= 0.14 to 1.27; p= 0.126), and cues to action 
(OR= 5.90; 95% CI= 1.30 to 26.74; p = 0.021). 
Conclusion: The use of HPV vaccine is associated with perceived susceptibility, perceived severi-
ty,  perceived threat, perceived benefit,  perceived barrier, and cues to action. Constructs in health 
belief model can be used to predict the use of HPV vaccine. 
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BACKGROUND 
Cervical cancer is excessive and uncontrol-
led cell growth around the cervix (Rasjidi, 
2010). Cervical cancer can come from cells 
around the cervix. Some cervical cancers 
begin at the transformation zone which is 
the transition from squamous cell type to 
cylindrical cell type. This cell does not im-
mediately turn into cervical cancer. Normal 
cervical cells because of the influence of 
carcinogens can develop gradually into pre-
cancerous cells and then become cancer 
cells (Nurwijaya et al., 2010). The trigger 
for the appearance of cervical cancer is an 
infection of several types of Human Papil-
loma Virus (HPV). The types of HPV that 
are often encountered in cervical cancer 
cases are types 16 and 18 over about 70% of 
cervical cancer cases occur (Hoque et al., 
2014). 
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Cervical cancer is a deadly disease 
that has a high prevalence rate both in the 
world and in Indonesia. To overcome this 
disease, it is necessary to change the beha-
vior from individuals to improve health and 
reduce the number of deaths due to cervical 
cancer. Many theories are used as a basis 
for changes in health behavior in individu-
als, one of them is the Health Belief Model 
theory developed by Stretcher & Rosen-
stock. In health belief theory, there are se-
veral variables underlying the change in 
health behavior, including, the perceived 
susceptibility variable due to cervical cancer 
is a personal perception of the possibility of 
developing cervical cancer.  
Perceived seriousness variable due to 
cervical cancer is the seriousness felt by the 
diagnosis of cervical cancer. Perceived thre-
at variable due to cervical cancer is a belief 
based on the perceived susceptibility and 
severity of cervical cancer. Perceived bene-
fits variable due to cervical cancer is one of 
the beliefs in the perceived action to reduce 
the risk of cervical cancer. The variable of 
perceived resistance due to cervical cancer 
is a suggested belief and negative potential 
of actions caused by cervical cancer. Varia-
ble of perceived cues due to cervical cancer 
is a strategy for prevention of cervical can-
cer (Urrutia, 2009). 
Cervical cancer is the second most 
common type of cancer affecting women 
worldwide after breast cancer. More than 
270,000 women die of cervical cancer each 
year, more than 85% of these deaths are in 
low-income countries (Shobeiri et al., 
2016). According to Urrutia's research 
(2009) data on cervical cancer susceptibi-
lity, cervical cancer in women is 88% of wo-
men go to health facilities when they have 
symptoms. Seriousness due to cervical can-
cer reported that 77% of women died of cer-
vical cancer. Barriers to prevention of cervi-
cal cancer 84% are caused by fear in women 
due to cervical cancer 50% of the shame in 
women due to cervical cancer. The benefits 
of preventing cervical cancer 89.9% early 
examination is that it can prevent death 
from cervical cancer. Cues to act to prevent 
cervical cancer 58% due to recommenda-
tions from health personnel, 30% recom-
mendations from friends. 
Cervical cancer attacks Indonesian 
women aged 15-44 years. Indonesia is the 
country with the highest number of cervical 
cancer incidence in Southeast Asia. The in-
cidence of cervical cancer per year in Indo-
nesia is estimated at 20,998 cases and the 
number of deaths from cervical cancer is 
9,498 people (ICO, 2016). Cervical cancer is 
the highest prevalence of cancer in Indone-
sia in 2013 at 0.8%. Based on estimation of 
the number of patients with cervical cancer, 
there are 21,313 patients in East Java provi-
nce (Infodatin, 2015). In 2015, cervical can-
cer patients in Kediri City were 33 patients 
and 3 died in patients (Kediri City Govern-
ment, 2016). 
Minister of Health Decree No. 769 of 
2010 concerning technical guidelines for 
controlling cervical cancer and breast can-
cer, there are four important components 
that become pillars in the treatment of cer-
vical cancer. The component consists of 
prevention of HPV infection by avoiding 
risk factors and HPV vaccination, early de-
tection through increased awareness and 
organized screening programs, diagnosis 
and management, and palliative care for 
advanced cases (Sari et al., 2014). Curren-
tly, secondary prevention is still the main 
focus to reduce the incidence of cervical 
cancer. Cervical cancer screening can be 
done through several methods including Vi-
sual Acetate Acid Inspection (IVA) method 
and pap smear test and performed on pe-
ople who have had sexual contact (Nurwija-
ya et al., 2010).  
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Cervical cancer can be treated early 
through screening but people are reluctant 
to check it out so that the incidence of cer-
vical cancer continues to increase. So other 
efforts are made to prevent cervical cancer 
by primary prevention using HPV vaccina-
tion. The HPV vaccine is a preventative vac-
cine against HPV types 16 and 18 that cause 
cervical cancer (Pratamaningtyas, 2013).  
There are two types of HPV vaccines 
that can prevent HPV infection, namely the 
bivalent and quadrivalent vaccines. Biva-
lent vaccines can only prevent HPV infecti-
ons types 16 and 18 that provide protection 
and reduce the risk of cervical cancer, vagi-
nal cancer, vulvar cancer. Several studies 
using bivalent vaccines show that vaccine 
effectiveness is quite high, reaching more 
than 90%. Quadrivalent vaccine is a vaccine 
that can prevent HPV infection types 16 and 
type 18 and types 6 and 11 infections that 
can cause genital warts or condyloma aku-
minata. The effectiveness of quadrivalent 
vaccine is estimated to be around 70-100% 
can reduce the incidence of cervical cancer 
cases to 90% (Radji, 2009). 
The effort to prevent cervical cancer is 
by using HPV vaccination. In Kediri, it is 
still rare to find women who do the HPV 
vaccine. In 2013, there were only 45 women 
who carried out the HPV vaccine through 
the Indonesian Midwives Association (IBI) 
in Kediri. Based on the phenomenon of the 
low number of women who carry out the 
HPV vaccine and the still high incidence of 
cervical cancer, and still limited research 
related to the theory of health belief health 
model behavior on the use of HPV vaccine 
by women in Indonesia, this study is nee-
ded.  
The purpose of this study was to ana-
lyze the application of health belief models 
about factors that influence the use of HPV 
vaccination to prevent cervical cancer in 
women in Kediri. 
 SUBJECTS AND METHOD 
1. Study Design 
This was an observational analytic study, 
with a case control approach conducted on 
10 February to 10 March 2017 in the area of 
Kediri, East Java Province. 
2. Population and Sampling  
The population in this study was women in 
Kediri. Total of 120 women were selected 
for this study by fixed disease sampling and 
divided into two groups including 40 
women who had used HPV vaccine as case 
group and 80 women who had not used 
HPV vaccine as control group. 
3. Study Variables 
The dependent variable was use of HPV 
vaccine. The independent variables were 
perceived susceptibility, perceived severity, 
perceived benefit, perceived threat, percei-
ved barrier, and cues to action. 
4. Operational Definitions of Variable 
Susceptibility perception was some-
one's subjective belief about the risk of con-
tracting the disease, the perceived possibili-
ty refers to someone's risk of having a parti-
cular disease or adverse health effects. 
Perceptions of seriousness was evalua-
tions of medical, clinical and social conse-
quences that may arise according to actions 
in preventing diseases. Perception of threat 
is an individual's urge to take action to pre-
vent or cure diseases caused by susceptibili-
ty and seriousness. 
Perception of benefits was the effective-
ness of strategies to reduce the threat of a 
disease that aims to improve a person's qu-
ality of life. Perceptions of barriers are ne-
gative consequences that arise when taking 
action both physically, psychologically, and 
financially. Signal perception acts as a fac-
tor that moves people to change their beha-
vior in health behavior.    
The use of HPV vaccine is a person's action 
to prevent cervical cancer by inserting a 
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drug containing protein antibodies that can 
kill the virus that causes cervical cancer. 
5. Reliability Test 
Based on the results of item-total correla-
tion reliability test, it was found that the 
measurement of susceptibility perception, 
perception of severity, threat perception, 
perceived usefulness, perception of barrier, 
cues to action, ie r calculated ≥ 0.20 and 
Cronbach alpha ≥ 0.60 so that all items 
were stated as reliable. 
Cronbach's alpha value on the instru-
ment of perception of susceptibility is 0.92 
and item correlation value is ≥0.44. Cron-
bach's alpha value on the perception of 
severity is 0.96 and item correlation value 
is ≥ 0.69. 
Cronbach's alpha value on the threat 
perception instrument is 0.91 and the 
correlation item value is ≥ 0.57. Cronbach's 
alpha value on the instrument of perceived 
usefulness is 0.91 and the item correlation 
value is ≥ 0.63. 
Cronbach's alpha value on the 
Cronbach alpha barriers perception instru-
ment is 0.89 and the item correlation value 
is ≥0.47. Cronbach's alpha value on Cron-
bach's alpha sign perception instrument is 
0.88 and item correlation value is ≥ 0.50. 
6. Data Analysis 
Univariate quantitative data analysis was 
performed to display characteristic data 
and descriptive research variables, bivariate 
analysis was conducted using Chi-Square 
test, and multivariate analysis with logistic 
regression analysis was used to predict 




1. Sample characteristics  
The presentation of characteristics of study 
subjects to women who use or do not use 
the HPV vaccine consisting of 40 women 
who use the HPV vaccine and 80 women 
who do not use the HPV vaccine or can be 
abbreviated as 40 women case subjects and 
80 women control subjects seen by age, 
education, marital status, employment, in-
come, number of children and family histo-
ry of cervical cancer. Table 1 shows that in 
the case group of 40 study subjects women 
who used the HPV vaccine, 47.5% of wo-
men were 30-50 years old, 37.5% were seni-
or high school graduates, 85% were marri-
ed, 37.5% were housewives, 62.5% had in-
come <1,500,000, 60% women have 1 child 
and 100% of women have no history of cer-
vical cancer in the body. The control group 
consisted of 80 study subjects women who 
did not use the HPV vaccine. A total of 
77.5% of women aged 30-50 years, 52.5% 
were bachelor graduates, 98.7% were mar-
ried, 41.25% were private employees, 
63.37% of women had income of Rp. 
1,500,000, 60% of women had 2 children, 
and 95% of women did not have history of 
cervical cancer in the family. 
Descriptive results of the study varia-
bles include dependent variable of the HPV 
vaccine use status, as well as the indepen-
dent variables of susceptibility perception 
variables, severity perception variables, 
threat perception variables, benefit percep-
tion variables, barrier perception variables, 
and action signaling variables can be seen 
in Table 2.  
2. Bivariate analysis 
Bivariate analysis describes the relationship 
between independent variables, namely 
perceptions of susceptibility, severity, thre-
ats, benefits, barriers/barriers, action sig-
nals and use of the HPV vaccine as the de-
pendent variable. The method used was the 
chi-square test can be seen in Table 3. 
3. Multivariate analysis 
Multivariate analysis explained about 
the relationship between independent 
variables namely perceived susceptibility, 
perceived severity, threat, benefit, barrier, 
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cues to action, and dependent variable which was the use of HPV Vaccine. 
 Table 1. The Characteristics of study subjects  
Characteristics Criteria 
Case Control 
n % n % 
Age ≤ 30 years 15 37.5 13 16.25 
 30-50 years 19 47.5 62 77.5 
 ≥ 30  years 6 15 5 6.25 
Education PS 4 10 0 0 
 JHS 7 17.5 6 7.5 
 SHS 15 37.5 23 28.75 
 D III 2 5 8 10 
 Bachelor 10 25 42 52.5 
 Post graduate 2 5 1 1.25 
Marital Status Single 0 0 0 0 
 Married 34 85 79 98.75 
 Widow/widower 6 15 1 1.25 
Occupation Housewife 15 37.5 17 21.25 
 Enterpreneur 7 17.5 23 28.75 
 Private employee 14 35 33 41.25 
 Civil servant 4 10 7 8.75 
Income <Rp 1,500,000 25 62.5 29 36.25 
 ≥Rp 1,500,000 15 37.5 51 63.75 
The number of 
children 
1 24 60 11 13.75 
2 14 35 48 60 
 3 7 17.5 9 11.25 
 4 5 12.5 2 2.5 
Cancer history With history 0 0 4 5 
 No history 40 100 76 95 
 
Tabel 2. Univariate analysis of study variables 
Variables Category n % 
The use of HPV vaccine  No HPV 80 66.7 
 Use HPV 40 33.3 
Perceived susceptibility Low < 20 42 35 
 High ≥ 20 78 65 
Perceived severity Low < 16 44 36.7 
 High ≥16 76 63.3 
Perceived threats Low < 16 51 42.5 
 High ≥ 16 69 57.5 
Perceived benefits Low < 17 52 43.3 
 High ≥ 17 68 56.7 
Perceived barriers Low < 16 75 625 
 High ≥ 16 45 37.5 
Perceived cues to act Low < 17 49 40.8 
 High ≥ 17 71 59.2 
 
There was a relationship between per-
ceived susceptibility and the use of HPV 
vaccine which was statistically insignificant. 
Women with high perceived susceptibility 
were 0.79 time less likely to use HPV 
vaccine compared to woman who have low 
perceived susceptibility (OR= 0.79; 95% 
CI= 0.23 to 2.70; p= 0.710). 
There was a relationship between per-
ceived severity and the use of HPV vaccine 
which was statistically significant. Women 
with high perceived severity were 5.19 times 
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more likely to use HPV vaccine compared 
to woman who have low perceived severity 
(OR= 5.19; 95% CI= 1.30 to 20.66; p= 
0.019). 
There was a relationship between per-
ceived threat and the use of HPV vaccine 
which was statistically insignificant. 
Women with high perceived threat were 
1.04 time more likely to use HPV vaccine 
than woman with low perceived threat 
(OR= 1.04; 95% CI= 0.32 to 3.35; p= 
0.942). 
 
Table 3. Bivariate Analysis of variables. 
Independent Variables OR  p 
Perceived Susceptibility 2.96  0.015 
Perceived Severity 9.00  0.001 
Perceived Threat 2.64  0.019 
Perceived Benefit 4.89  0.001 
Perceived Barrier 1.88  0.011 
Cues to Action 8.56  0.001 
 
Table 4. Multiple Logistic Regression Analysis 
Independent Variables OR 
95% CI 
p 
Lower limit Upper limit 
Perceived Susceptibility 0.79 0.23 2.70 0.710 
Perceived Severity 5.19 1.30 2066 0.019 
Perceived Threat 1.04 0.32 3.35 0.942 
Perceived Benefit 1.33 0.40 4.38 0.638 
Perceived Barrier 0.42 0.14 1.27 0.126 
Cues to Action 5.90 1.30 26.74 0.021 
N Observation = 120     
-2 Log Likelihood 121.89    
Nagelkerke R Square 31.5    
 
There was a relationship between per-
ceived benefit and the use of HPV vaccine 
which was statistically insignificant. (p= 
0.638). Women with high perceived benefit 
were 1.33 times more likely to use HPV vac-
cine compared to woman who have low per-
ceived benefit (OR= 1.33; 95% CI= 0.40 to 
4.38; p= 0.638). 
There was a relationship between per-
ceived barrier and the use of HPV vaccine 
which was statistically insignificant. 
Women with high perceived barrier were 
0.42 time less likely to use HPV vaccine 
compared to woman who have low 
perceived barrier (OR= 0.42; 95% CI= 0.14 
to 1.27; p= 0.126).  
There was a relationship between per-
ceived cues to action and the use of HPV 
vaccine which was statistically significant 
(p= 0.021). Women with high perceived 
cues to action were 5.90 times more likely 
to use HPV vaccine compared to woman 
who have low perceived cues to action 




1. The Use of HPV Vaccine on Percei-
ved Susceptibility  
The result of this study showed that there 
was an effect of perceived susceptibility on 
the use of HPV vaccine and it was statisti-
cally insignificant. Perceived susceptibility 
was one of the strongest perceptions for 
someone to adopt health behavior. This 
study showed that women who felt them-
selves susceptible to cervical cancer would 
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use the HPV vaccine to prevent cervical 
cancer and vice versa.  
The result of this study was in line 
with a study done by Puri (2016) which 
stated that there was an effect of perceived 
susceptibility on the completeness of im-
munization status. Mothers who felt their 
children were vulnerable to diseases that 
can be prevented by immunization would 
take preventive action by vaccines and vice 
versa. A study by Wakhida (2016) stated 
that there was an effect of perceived suscep-
tibility on the use of VCT. Pregnant women 
who have a high perceived susceptibility to 
HIV/AIDS would increase the use of VCT. A 
study by Indrian (2014) showed that there 
was a relationship between perceived sus-
ceptibility of the diseases and health ser-
vices on health belief model. This showed 
that if the disease susceptibility was 
increased, health services in health belief 
models would also increased. 
According to Rosenstock (1980) in 
Wakhida (2016), perceived susceptibility 
was a person's subjective perception of the 
risk of contracting the disease. This would 
help someone to take preventive and treat-
ment actions, because someone felt vul-
nerable to the disease. This made the health 
trust model depended on individual percep-
tions. This was related to the evaluation of 
the use of services, whether to receive con-
sequences for medical and clinical services 
or face the social conditions.  
A person's beliefs about being suscep-
tible or not susceptible to illness and their 
perception of the benefits of disease pre-
vention were influenced by someone's 
readiness to take an action. Resenstock 
(1982) in Ningrum (2016) stated that 
people who have perceived susceptibility 
about the possibility of being affected by a 
disease would affect their behavior espe-
cially to prevent the disease or seek the 
treatment. Those who felt that they could 
be affected by the disease would feel 
threatened more quickly. 
A person would take an action to 
prevent the disease if he/she felt that it was 
possible. Perceived susceptibility of an indi-
vidual in a situation depend on the percep-
tions about the risks faced in a particular si-
tuation. Generally, the susceptibility of cer-
vical cancer that was felt by women did not 
give much motivation to use the HPV vac-
cine. Most people acted after experiencing 
the disease so there were some women who 
did not use the vaccine. 
2. The Use of HPV Vaccine on Percei-
ved Severity 
The result of this study showed that there 
was an effect of perceived severity on the 
use of HPV vaccine and it was statistically 
significant. The variable of perceived seri-
ousness in this study was perceptions about 
the dangers of cervical cancer that can be 
prevented by using the HPV vaccine. This 
study showed that women who have a per-
ception that cervical cancer can be pre-
vented early by using the HPV vaccine 
would use the HPV vaccine, and vice versa. 
The result of this study was in line 
with a study done by Wigati (2016) which 
revealed that there was an effect of per-
ceived severity by doing an IVA test, the 
more severe a disease, then someone would 
make an effort to do prevention, which was 
the IVA test for early detection of cervical 
cancer. A study by Sutrisni (2016) showed 
that there was an effect of perceived seve-
rity/perceived seriousness and HIV test, 
mothers have a perception that a serious 
illness which was known earlier could be 
prevented, one of the preventions was by 
using HIV test to determine the status of 
transmitted by AIDS.  
According to Ningrum (2016) there 
was a relationship between perceived seve-
rity and the use of VCT. Pregnant women 
Nugrahani et al./ Factors Associated with the Use of HPV Vaccine 
e-ISSN: 2549-1173 (online)   79 
who have high perceived severity about 
HIV/AIDS would increase the use of VCT. 
The results of this study were relevant 
to the Health Belief Model theory. The per-
ceived severity/seriousness determine whe-
ther there was a prevention of the disease 
or not. Perceived seriousness was often 
based on medical information and know-
ledge or belief that he/she would have dif-
ficulties due to the diseases (Hyden, 2009).  
Perceived severity determined if there 
was preventive actions for the disease 
which in this case was cervical cancer, 
which made the individuals have a willing-
ness to seek information and use the HPV 
vaccine to prevent cervical cancer. This was 
because they did not want to be affected by 
the disease, therefore, they would make an 
effort to prevent the disease. 
3. The Use of HPV Vaccine on Percei-
ved Threat 
The result of analysis showed that there 
was an effect of perceived threat on the use 
of HPV vaccine and it was statistically non-
significant. This study showed that women 
who have perceived threat that cervical 
cancer was a threatening disease would to 
take preventive action by using the HPV 
vaccine. 
The result of this study was in line 
with a study by Sutrisni (2016) which stated 
that there was an effect of perceived threat 
and the willingness of HIV test. Mothers 
who have the perception that HIV/AIDS 
disease was a threatening disease would 
take a preventive action which was HIV 
test. A study by Puri (2016) showed that 
there was an effect of perceived threat and 
the completeness of immunization status. 
Mothers who have a perception that a 
disease that can be prevented by immuniza-
tion was a threatening disease, then they 
would do the immunizations. A study by 
Wigati (2016) revealed that there was an 
effect of perceived threat and the imple-
mentation of IVA test. Women who have a 
perception that cervical cancer was a 
threatening disease would carry out an IVA 
test. 
According to Rosenstock (1982) in 
Noorkasiani (2009), individual perceptions 
about the possibility of being affected by a 
disease were perceived susceptibility. Those 
who felt that they can be affected by the di-
sease would feel threatened more quickly. 
An individual's views of the severity of the 
disease (perceived seriousness) were the 
risks and difficulties that would be expe-
rienced from the disease. The more severe 
the risk of a disease, the more likely the 
individual to be affected by the disease. 
This leads to the enhancement of the 
perceived threats. This threat encouraged 
the individuals to take an action to prevent 
or cure the diseases. 
This study showed that women consi-
dered that cervical cancer was a disease 
that can be prevented by using HPV vaccine 
and it was a non-self-threatening disease 
(69%). This was because the understand-
ings of each individual of the threats that 
can be caused by cervical cancer and can be 
prevented by the HPV vaccine depend on 
the knowledge of the disease. 
4. The Use of HPV Vaccine on Percei-
ved Benefit 
The result of analysis showed that there 
was an effect of perceived benefit on the use 
of HPV vaccine and it was statistically non-
significant. This study showed that women 
who felt that conducting the HPV vaccine 
was useful for preventing cervical cancer 
would do the vaccination and vice versa. 
The result of this study was in line 
with a study by Wakhida (2016) which re-
vealed that there was an effect of perceived 
benefit and the use of VCT. Pregnant 
women who have high perceived benefits 
about HIV/AIDS would use the VCT test. A 
study by Ningrum (2016) revealed that 
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there was an effect of perceived benefits 
and cadre performance on the control of 
tuberculosis cases. Cadres who have great 
perceived benefits would control the 
tuberculosis cases properly rather than 
cadres who have small perceived benefits. 
Wigati (2016) stated that there was an 
effect of perceived benefit and the imple-
mentation of IVA test. Women who felt the 
benefit of an action in avoiding the disease 
would prefer to take the actions. 
Based on the Health Belief Model the-
ory, Rosenstock (1982) stated that indivi-
duals would do a behavior if they believe 
that their behavior was beneficial for 
themselves and the environment, but if the 
benefits were not appropriate, they would 
not do the behavior. Women were encou-
raged to conduct HIV vaccine so that they 
can prevent cervical cancer and they would 
feel safe after conducting the vaccination of 
cervical cancer. Perceived benefit was a 
person's opinion about the usefulness of a 
new behavior in reducing the risk of 
disease. 
This study showed that women would 
use the HPV vaccine if it has a benefit to 
prevent cervical cancer and vice versa, the-
refore, the presentation of women who did 
not use the HPV vaccine was still found due 
to the lack of information about the 
vaccine. Perceived benefit of using the HPV 
vaccine has not been felt directly for most 
women because women in reproductive age 
should have a pap smear test before con-
ducting a vaccination to find out whether 
there was a pre-cancerous lesion or not. 
5. The Use of HPV Vaccine on Percei-
ved Barrier 
The result of analysis showed that there 
was an effect of perceived barrier on the use 
of HPV vaccine and it was statistically 
insignificant. This study showed that most 
women who felt that there were some 
barriers in using the HPV vaccine chose not 
to do the HPV vaccine as a preventive 
action for the cervical cancer, and vice 
versa. 
The result of this study was in line 
with a study done by Puri (2016) which 
stated that there was an effect of perceived 
barrier on the completeness of immuniza-
tion status. Mothers who felt that there 
were some barriers in immunizing their 
baby chose not to take preventive action, 
and vice versa. A study done by Wigati 
(2016) stated that there was an effect of 
perceived barrier on the implementation of 
IVA test. Women who have a perception of 
a major barrier in doing the behavior were 
less likely to conduct IVA test. 
A study of Sutrisni (2016) revealed 
that there was an effect of perceived barrier 
on the willingness to do HIV test. Pregnant 
women who felt that there were some 
barriers in doing HIV test chose not to take 
preventive actions, and vice versa. 
The result of this study was in accor-
dance with the Health Belief Model theory 
by Rosenstock (1982) in Ningrum (2016), 
which stated that taking an action to 
prevent a disease or seeking treatment was 
affected by perceived barrier, which was the 
barriers that arised in doing an action. A 
common barrier experienced by a person in 
determining health actions or utilizing 
health services was dominated by personal 
constraints. Perceived barrier was a 
determinant of behavioral changes.  
Perceived barriers experienced by wo-
men who want to use the HPV vaccine in 
this study stated that there were some bar-
riers such as lack of information about HPV 
vaccine, the high cost of cervatre vaccine 
which was around Rp. 700,000 for one vac-
cine, lack of health facilities which provide 
HPV vaccines, women’s fear in conducting 
vaccines, and there was no government re-
gulation which required the women to con-
Nugrahani et al./ Factors Associated with the Use of HPV Vaccine 
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duct HPV vaccine so that there were some 
women who refused to do the HPV vaccine.  
6. The Use of HPV Vaccine on Percei-
ved Cues to Action 
The result of analysis showed that there 
was an effect of cues to action on the use of 
HPV vaccine and it was statistically signifi-
cant. Women who have high cues to action 
about cervical cancer would use the HPV 
vaccine to prevent cervical cancer and vice 
versa. 
The result of this study was in line 
with a study done by Wakhida (2016) which 
stated that there was an effect of high cues 
to action about HIV/AIDS disease on the 
enhancement of VCT utilization. Pregnant 
women who have high cues to action would 
use VCT. A study done by Ningrum (2016) 
showed that there was an effect of the en-
couragement to act and cadre performance 
on tuberculosis control. Cadres who have 
strong encouragement to act have good per-
formance in controlling tuberculosis cases 
and vice versa. A study of Wigati (2016) 
revealed that there was an effect of cues to 
action perception on the implementation of 
IVA test. Women who experienced a 
decrease in cues action were less likely to 
conduct IVA test. 
The result of this study was in accor-
dance with the Health Belief Model theory 
by Rosenstock (1982) in Ningrum (2016) 
which stated that in taking an action, there 
was a motivating factor to accept or ignore 
the action. Encouragement was consisted of 
internal and external encouragement. 
In this study, women's cues to action 
in using HPV vaccine to prevent cervical 
cancer could come from themselves or from 
outside. Self-encouragement could be in the 
form of intention to use HPV vaccine in 
anticipation of cervical cancer in women 
while outside encouragements were from 
family history of cervical cancer, friend's 
invitation, and counseling from health 
personnel about HPV vaccine, therefore, 
most women (59.2%) in this study have 
high cues to action. 
Based on the results of this study, it 
can be concluded that construct of health 
belief model consisting of perceived suscep-
tibility, perceived severity, perceived threat, 
perceived benefits, perceived barriers, and 
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